URGN logo

UroGen Pharma (URGN) Depreciation And Amortization

Annual D&A

$1.19 M
-$519.00 K-30.44%

December 31, 2024

Summary

Performance

1-Year Change

-30.44%

3-Year Change

-33.11%

5-Year Change

-10.42%

15-Year Change

+472.95%

URGN Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.64%
URGN annual depreciation & amortization is higher than 41.64% of companies in Healthcare sector

High & Low

All-time High

$2.04 M
URGN annual depreciation & amortization is currently -41.98% below its historical high of $2.04 million

3-Year Low

$1.19 M
URGN annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
URGN previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
URGN next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$187.18 M
URGN annual total expenses is $187.18 million

Annual Operating Expenses

$178.30 M
URGN annual total operating expenses is $178.30 million

Annual Cost Of Goods Sold

$8.88 M
URGN annual cost of goods sold is $8.88 million

Annual Interest Expense

$12.52 M
URGN annual interest expense is $12.52 million

Quarterly D&A

$306.00 K
+$40.00 K+15.04%

December 1, 2024

Summary

Performance

3-Month Change

+15.04%

1-Year Change

+15.04%

3-Year Change

-32.15%

5-Year Change

-23.5%

URGN Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.31%
URGN quarterly depreciation & amortization is higher than 41.31% of companies in Healthcare sector

High & Low

All-time High

$615.00 K
URGN quarterly depreciation & amortization is currently -50.24% below its historical high of $615.00 thousand

3-Year Low

$263.00 K
URGN quarterly depreciation & amortization is currently +16.35% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
URGN previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 13, 2025
URGN next earnings announcement is scheduled for May 13, 2025

Related metrics

Quarterly Total Expenses

$52.22 M
URGN quarterly total expenses is $52.22 million

Quarterly Operating Expenses

$49.75 M
URGN quarterly total operating expenses is $49.75 million

Quarterly Cost Of Goods Sold

$2.47 M
URGN quarterly cost of goods sold is $2.47 million

Quarterly Interest Expense

$3.89 M
URGN quarterly interest expense is $3.89 million

TTM D&A

$1.19 M
-$118.00 K-9.05%

December 1, 2024

Summary

Performance

3-Month Change

-9.05%

1-Year Change

-9.05%

3-Year Change

-33.11%

5-Year Change

-10.42%

URGN TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.66%
URGN TTM depreciation & amortization is higher than 40.66% of companies in Healthcare sector

High & Low

All-time High

$2.04 M
URGN TTM depreciation & amortization is currently -41.98% below its historical high of $2.04 million

3-Year Low

$1.19 M
URGN TTM depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
URGN previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 13, 2025
URGN next earnings announcement is scheduled for May 13, 2025

Related metrics

Annual Total Expenses

$187.18 M
URGN annual total expenses is $187.18 million

Annual Operating Expenses

$178.30 M
URGN annual total operating expenses is $178.30 million

TTM Cost Of Goods Sold

$8.88 M
URGN TTM cost of goods sold is $8.88 million

TTM Interest Expense

$12.52 M
URGN TTM interest expense is $12.52 million

URGN Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-30.4%+15.0%-9.1%
3 y3 years-33.1%-32.1%-33.1%
5 y5 years-10.4%-23.5%-10.4%

URGN Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-34.7%at low-35.7%+16.4%-35.4%at low
5 y5-year-42.0%at low-50.2%+16.4%-42.0%at low
alltimeall time-42.0%+949.6%-50.2%+1700.0%-42.0%+2535.6%

UroGen Pharma Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2024
$1.19 M(-30.4%)
-
-
Dec 2024
-
$306.00 K(+15.0%)
$1.19 M(-9.0%)
Sep 2024
-
$266.00 K(+1.1%)
$1.30 M(-10.3%)
Jun 2024
-
$263.00 K(-25.1%)
$1.45 M(-10.4%)
Mar 2024
-
$351.00 K(-17.2%)
$1.62 M(-4.9%)
Dec 2023
$1.71 M(-6.2%)
$424.00 K(+2.2%)
$1.71 M(-1.5%)
Sep 2023
-
$415.00 K(-3.7%)
$1.73 M(-1.1%)
Jun 2023
-
$431.00 K(-0.9%)
$1.75 M(-2.5%)
Mar 2023
-
$435.00 K(-3.3%)
$1.80 M(-1.2%)
Dec 2022
$1.82 M(+2.5%)
$450.00 K(+3.4%)
$1.82 M(-0.1%)
Sep 2022
-
$435.00 K(-8.6%)
$1.82 M(-0.9%)
Jun 2022
-
$476.00 K(+4.4%)
$1.83 M(+1.9%)
Mar 2022
-
$456.00 K(+1.1%)
$1.80 M(+1.6%)
Dec 2021
$1.77 M(-13.3%)
$451.00 K(-0.2%)
$1.77 M(-8.5%)
Sep 2021
-
$452.00 K(+2.3%)
$1.94 M(-2.3%)
Jun 2021
-
$442.00 K(+3.3%)
$1.98 M(-1.6%)
Mar 2021
-
$428.00 K(-30.4%)
$2.02 M(-1.4%)
DateAnnualQuarterlyTTM
Dec 2020
$2.04 M(+54.4%)
$615.00 K(+23.5%)
$2.04 M(+11.8%)
Sep 2020
-
$498.00 K(+4.8%)
$1.83 M(+11.5%)
Jun 2020
-
$475.00 K(+4.2%)
$1.64 M(+11.5%)
Mar 2020
-
$456.00 K(+14.0%)
$1.47 M(+11.2%)
Dec 2019
$1.32 M(+217.5%)
$400.00 K(+29.0%)
$1.32 M(+33.5%)
Sep 2019
-
$310.00 K(+1.3%)
$992.00 K(+34.1%)
Jun 2019
-
$306.00 K(-0.6%)
$740.00 K(+52.6%)
Mar 2019
-
$308.00 K(+352.9%)
$485.00 K(+16.3%)
Dec 2018
$417.00 K(+101.4%)
$68.00 K(+17.2%)
$417.00 K(+2.5%)
Sep 2018
-
$58.00 K(+13.7%)
$407.00 K(+11.2%)
Jun 2018
-
$51.00 K(-78.8%)
$366.00 K(-9.0%)
Mar 2018
-
$240.00 K(+313.8%)
$402.00 K(+94.2%)
Dec 2017
$207.00 K(-2.8%)
$58.00 K(+241.2%)
$207.00 K(+38.9%)
Sep 2017
-
$17.00 K(-80.5%)
$149.00 K(+12.9%)
Jun 2017
-
$87.00 K(+93.3%)
$132.00 K(+193.3%)
Mar 2017
-
$45.00 K
$45.00 K
Dec 2016
$213.00 K(+88.5%)
-
-
Dec 2015
$113.00 K
-
-

FAQ

  • What is UroGen Pharma annual depreciation & amortization?
  • What is the all time high annual D&A for UroGen Pharma?
  • What is UroGen Pharma annual D&A year-on-year change?
  • What is UroGen Pharma quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for UroGen Pharma?
  • What is UroGen Pharma quarterly D&A year-on-year change?
  • What is UroGen Pharma TTM depreciation & amortization?
  • What is the all time high TTM D&A for UroGen Pharma?
  • What is UroGen Pharma TTM D&A year-on-year change?

What is UroGen Pharma annual depreciation & amortization?

The current annual D&A of URGN is $1.19 M

What is the all time high annual D&A for UroGen Pharma?

UroGen Pharma all-time high annual depreciation & amortization is $2.04 M

What is UroGen Pharma annual D&A year-on-year change?

Over the past year, URGN annual depreciation & amortization has changed by -$519.00 K (-30.44%)

What is UroGen Pharma quarterly depreciation & amortization?

The current quarterly D&A of URGN is $306.00 K

What is the all time high quarterly D&A for UroGen Pharma?

UroGen Pharma all-time high quarterly depreciation & amortization is $615.00 K

What is UroGen Pharma quarterly D&A year-on-year change?

Over the past year, URGN quarterly depreciation & amortization has changed by +$40.00 K (+15.04%)

What is UroGen Pharma TTM depreciation & amortization?

The current TTM D&A of URGN is $1.19 M

What is the all time high TTM D&A for UroGen Pharma?

UroGen Pharma all-time high TTM depreciation & amortization is $2.04 M

What is UroGen Pharma TTM D&A year-on-year change?

Over the past year, URGN TTM depreciation & amortization has changed by -$118.00 K (-9.05%)